Trial Search Results

PRESERVE-Zenith® Iliac Branch System Clinical Extended Study

The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation System. This system is made up of two devices: the Zenith® Branch Endovascular Graft-Iliac Bifurcation and the ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Cook Group Incorporated

Stanford Investigator(s):

Intervention(s):

  • Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation System

Eligibility


Inclusion Criteria:

   - An aortioiliac or iliac aneurysm

   - An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the
   common lilac artery

Exclusion Criteria:

   - Less than 18 years of age

   - Inability or refusal to give informed consent

   - Disease considerations that would compromise patient safety or study outcomes

   - Unsuitable arterial anatomy

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting